Markt geschlossen· · HKD · Daten können verzögert sein
Kurse können verzögert sein und dienen nur zu Informationszwecken - keine Anlageberatung.
Gesamtrendite inklusive Dividenden.
Wo der Kurs im Verhältnis zu seinen 50- und 200-Tage-Durchschnitten steht.
Makkler Fair Value, Finanzgesundheit, Analystenmeinung, Vergleichsunternehmen und MakklerAI.
Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced its interim results for the six months ended June 30, 2026 (the "Reporting Period") on August 21, 2026. During the first half of 2026, the Group accelerated commercialization across its core businesses while delivering significant improvements in operational efficiency, profitability and cash generation.
As global markets grapple with inflation pressures and geopolitical uncertainties, Asian equities present a compelling narrative amidst these broader economic challenges. In this environment, identifying undervalued stocks can be particularly advantageous, as they may offer potential value relative to their intrinsic worth despite the prevailing market volatility.
As inflation pressures rise amid higher energy costs, Asian markets are navigating a complex landscape shaped by geopolitical uncertainties and fluctuating commodity prices. In this environment, identifying undervalued stocks can offer potential opportunities for investors seeking to capitalize on resilient sectors or companies with strong fundamentals.
Aktuelle Schlagzeilen Dritter zu diesem Unternehmen, getrennt von Makklers eigener Redaktion und mit Verlinkung zum Herausgeber. Für die Richtigkeit ist der jeweilige Herausgeber verantwortlich.